These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 27301873)
1. TAT Peptide-Conjugated Magnetic PLA-PEG Nanocapsules for the Targeted Delivery of Paclitaxel: In Vitro and Cell Studies. Koutsiouki K; Angelopoulou A; Ioannou E; Voulgari E; Sergides A; Magoulas GE; Bakandritsos A; Avgoustakis K AAPS PharmSciTech; 2017 Apr; 18(3):769-781. PubMed ID: 27301873 [TBL] [Abstract][Full Text] [Related]
2. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel. Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600 [TBL] [Abstract][Full Text] [Related]
3. Polymer-polymer conjugation to fabricate multi-block polymer as novel drug carriers: poly(lactic acid)-poly(ethylene glycol)-poly(L-lysine) to enhance paclitaxel target delivery. Liu Y; Liu C; Li M; Liu F; Feng L; Zhang L; Zhang N J Biomed Nanotechnol; 2014 Jun; 10(6):948-58. PubMed ID: 24749390 [TBL] [Abstract][Full Text] [Related]
4. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related]
5. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer. He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524 [TBL] [Abstract][Full Text] [Related]
6. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
7. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer. Lv S; Tang Z; Li M; Lin J; Song W; Liu H; Huang Y; Zhang Y; Chen X Biomaterials; 2014 Jul; 35(23):6118-29. PubMed ID: 24794923 [TBL] [Abstract][Full Text] [Related]
8. Poly(d,l-lactide)/polyethylene glycol micro/nanofiber mats as paclitaxel-eluting carriers: preparation and characterization of fibers, in vitro drug release, antiangiogenic activity and tumor recurrence prevention. Hobzova R; Hampejsova Z; Cerna T; Hrabeta J; Venclikova K; Jedelska J; Bakowsky U; Bosakova Z; Lhotka M; Vaculin S; Franek M; Steinhart M; Kovarova J; Michalek J; Sirc J Mater Sci Eng C Mater Biol Appl; 2019 May; 98():982-993. PubMed ID: 30813105 [TBL] [Abstract][Full Text] [Related]
9. PEGylated-Paclitaxel and Dihydroartemisinin Nanoparticles for Simultaneously Delivering Paclitaxel and Dihydroartemisinin to Colorectal Cancer. Phung CD; Le TG; Nguyen VH; Vu TT; Nguyen HQ; Kim JO; Yong CS; Nguyen CN Pharm Res; 2020 Jun; 37(7):129. PubMed ID: 32548664 [TBL] [Abstract][Full Text] [Related]
10. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery. Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039 [TBL] [Abstract][Full Text] [Related]
11. Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology. Huang X; Zhang Y; Yin G; Pu X; Liao X; Huang Z; Chen X; Yao Y J Mater Sci Mater Med; 2015 Feb; 26(2):95. PubMed ID: 25649516 [TBL] [Abstract][Full Text] [Related]
12. Preparation and investigation of high solid content PTX-loaded nanoparticles dispersion via nanoprecipitation method. Xiang Y; Xiao M; Han S; Xu S; Cao Y; Lv Z; Liu J; Liu J; Deng L; Dong A J Biomater Sci Polym Ed; 2014; 25(11):1144-58. PubMed ID: 24894948 [TBL] [Abstract][Full Text] [Related]
13. Preparation and biological evaluation of paclitaxel loaded biodegradable PCL/PEG nanoparticles for the treatment of human neuroendocrine pancreatic tumor in mice. Dubey N; Shukla J; Hazari PP; Varshney R; Ganeshpurkar A; Mishra AK; Trivedi P; Bandopadhaya GP Hell J Nucl Med; 2012; 15(1):9-15. PubMed ID: 22413106 [TBL] [Abstract][Full Text] [Related]
14. Sustained release of PTX-incorporated nanoparticles synergized by burst release of DOX⋅HCl from thermosensitive modified PEG/PCL hydrogel to improve anti-tumor efficiency. Xu S; Wang W; Li X; Liu J; Dong A; Deng L Eur J Pharm Sci; 2014 Oct; 62():267-73. PubMed ID: 24931190 [TBL] [Abstract][Full Text] [Related]
15. Cell-Penetrating Peptide Modified PEG-PLA Micelles for Efficient PTX Delivery. Shuai Q; Cai Y; Zhao G; Sun X Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182734 [TBL] [Abstract][Full Text] [Related]
16. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency. Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400 [TBL] [Abstract][Full Text] [Related]
17. Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis. Zhang H; Hu H; Zhang H; Dai W; Wang X; Wang X; Zhang Q Nanoscale; 2015 Jun; 7(24):10790-800. PubMed ID: 26038337 [TBL] [Abstract][Full Text] [Related]
18. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo. Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098 [TBL] [Abstract][Full Text] [Related]
19. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy. Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504 [TBL] [Abstract][Full Text] [Related]